367 related articles for article (PubMed ID: 18813800)
1. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
Hsieh TC; Wu JM
Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
[TBL] [Abstract][Full Text] [Related]
2. gamma-Tocotrienol controls proliferation, modulates expression of cell cycle regulatory proteins and up-regulates quinone reductase NQO2 in MCF-7 breast cancer cells.
Hsieh TC; Elangovan S; Wu JM
Anticancer Res; 2010 Jul; 30(7):2869-74. PubMed ID: 20683025
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
4. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
Akl MR; Ayoub NM; Sylvester PW
Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
[TBL] [Abstract][Full Text] [Related]
6. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
Tiwari RV; Parajuli P; Sylvester PW
Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
[TBL] [Abstract][Full Text] [Related]
8. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
10. Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin.
Hsieh TC; Wu JM
Anticancer Res; 2009 Oct; 29(10):4025-32. PubMed ID: 19846946
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
12. Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate, resveratrol and curcuma.
Baatout S; Derradji H; Jacquet P; Mergeay M
Int J Mol Med; 2005 Feb; 15(2):337-52. PubMed ID: 15647852
[TBL] [Abstract][Full Text] [Related]
13. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
14. Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells.
Yap WN; Zaiden N; Tan YL; Ngoh CP; Zhang XW; Wong YC; Ling MT; Yap YL
Cancer Lett; 2010 May; 291(2):187-99. PubMed ID: 19926394
[TBL] [Abstract][Full Text] [Related]
15. Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol.
Gopalan A; Yu W; Sanders BG; Kline K
Cancer Lett; 2013 Jan; 328(2):285-96. PubMed ID: 23063651
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
Masuda M; Suzui M; Lim JT; Weinstein IB
Clin Cancer Res; 2003 Aug; 9(9):3486-91. PubMed ID: 12960141
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth.
Snyder RM; Yu W; Jia L; Sanders BG; Kline K
Nutr Cancer; 2008; 60(3):401-11. PubMed ID: 18444175
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
Bachawal SV; Wali VB; Sylvester PW
BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells.
Liu HK; Wang Q; Li Y; Sun WG; Liu JR; Yang YM; Xu WL; Sun XR; Chen BQ
J Nutr Biochem; 2010 Mar; 21(3):206-13. PubMed ID: 19195866
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]